四维彩色多普勒超声联合血清学PSA检测在前列腺癌诊断中的临床价值

目的探讨四维彩色多普勒超声联合血清学PSA在前列腺癌诊断中的临床应用价值。方法将166例前列腺疾病患者随机均分为实验组和对照组,各83例。对照组术前采用四维彩色多普勒超声诊断,实验组术前采用四维彩色多普勒超声联合血清学PSA值诊断,对比二者对前列腺癌的诊断准确率。结果对照组83例患者中,诊断为前列腺癌48例,误诊10例,准确率82.8%(48/58);实验组83例患者中,超声和血清学PSA均诊断为前列腺癌58例,误诊5例,准确率为92.1%(58/63);2组诊断准确率比较,差异有统计学意义(P<0.05)。结论四维彩色多普勒超声结合PSA检查可以提高前列腺癌的诊断率,减少误诊、漏诊,有一定的临床应用价值。

Objective To investigate the clinic application of four-dimensional ultrasound combined with PSA in the diagnosis of human＇s prostatic carcinoma tissue. Methods 166 cases with prostatic disease admitted in hospital were randomly divided into two groups, observation group of 83 patients and control group of patients. Observation group preoperative combined PSA and four-dimensional ultrasound diagnosis, and control group only depend on four-dimensional ultrasound diagnosis. Compare the diagnostic accuracy of these two groups. Results The 83 patients diagnosed with prostatic cancer in 48 cases（82.8%）, 10 cases misdiagnosed as benign lesions control group of 83 patients diagnosed by both four- dimensional ultrasound diagnosis and serum PSA with prostatic cancer in 58 cases （92.1%） and malignant 5 cases were misdiagnosed as benign lesions, diagnostic rate had significantly different（P〈0.05）. Conclusion The combination of four-dimensional ultrasound examination and PSA can improve the diagnosis of prostatic cancer, has great application value in the clinical diagnose of prostatic cancer.